Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-08-28Clinical Trial Update: Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer [Phase 1, Phase 2]
The clinical trial evaluating Sym004 in combination with nivolumab for EGFR-amplified squamous non-small cell lung cancer has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating gefitinib with or without simvastatin in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2017-08-25Clinical Trial Update: IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer [NA]
Clinical trial update examining IMRT timing in combination with an EGFR-TKI for stage IV non-small cell lung cancer.
-
CLINICAL_TRIALS withdrawal · 2017-08-25Clinical Trial Update: MRI Adaptive Replanning Using ViewRay [NA]
The clinical trial NCT02950792 evaluating MRI adaptive replanning with ViewRay for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2017-08-22Clinical Trial Update: A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
This clinical trial update outlines a study assessing gene mutation status in cerebrospinal fluid, blood, and tumor tissue from patients wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-08-22Clinical Trial Update: Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer [NA]
A clinical trial evaluating a cyclin B1 peptide-pulsed autologous dendritic cell vaccine for resectable non-small cell lung cancer has been …
-
CLINICAL_TRIALS research · 2017-08-22Clinical Trial Update: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now
A registry study update from AstraZeneca on the evolution of lung cancer therapy implementation and outcomes. The study has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Circulating Tumor DNA in Patients at High Risk for Lung Cancer
This clinical trial update notes a terminated study investigating circulating tumor DNA as a biomarker in individuals at high risk for lung …
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Apatinib in heavily pretreated advanced non-squamous non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer [Phase 1]
This Phase 1 trial update reports results for a NY-ESO-1 vaccine with the GLA-SE adjuvant in patients with unresectable or metastatic cancer…
-
CLINICAL_TRIALS research · 2017-08-17Clinical Trial Update: 89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update investigating 89Zr-labeled pembrolizumab for imaging in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: A Study of Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update for advanced or metastatic non-small cell lung cancer. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating evofosfamide (TH-302) in combination with pemetrexed versus placebo in non-squamous non-small cell lung cancer was …
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Powered Surgical Stapler in VATS Lung Resection Procedures in China
This trial evaluated a powered surgical stapler during video-assisted thoracoscopic lung resections for non-small cell lung cancer in China …
-
FDA approval · 2017-08-09FDA Approved: DOCETAXEL — Original Application (Jiangsu Hengrui Pharmaceuticals Co., Ltd.)
FDA approved a generic version of docetaxel under an original ANDA from Jiangsu Hengrui Pharmaceuticals Co., Ltd., enabling market authoriza…
-
CLINICAL_TRIALS research · 2017-08-08Clinical Trial Update: Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients [NA]
Clinical trial comparing qPCR to immunohistochemistry and FISH for detecting ALK fusion mutations in FFPE tissue from patients with non-smal…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease [Phase 2]
This phase 2 clinical trial update evaluates the effectiveness and safety of adding bevacizumab to first-line chemotherapy in patients with …
-
FDA approval · 2017-08-03FDA Approved: GEMCITABINE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's gemcitabine injectable drug as an original application, providing a generic version of the anticancer agent…
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC [Phase 2]
Phase 2 BATTLE program update reports results for Erlotinib in previously treated advanced non-small cell lung cancer, with the trial status…
-
CLINICAL_TRIALS research · 2017-08-01Clinical Trial Update: Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) [NA]
A completed clinical trial update describing the characterization of circulating tumor cells captured via c-MET (CTC-MET) across multiple ca…
-
CLINICAL_TRIALS withdrawal · 2017-07-31Clinical Trial Update: Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating Vigil in combination with nivolumab for advanced/metastatic non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating nelfinavir with chemoradiation for non-small cell lung cancer was terminated, and results were posted in 2017. Th…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung
An observational study evaluating first-line bevacizumab (Avastin) in patients with lung adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation [Phase 4]
Phase 4 trial update evaluating high-dose icotinib in advanced non-small cell lung cancer with an EGFR exon 21 mutation.
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib [Phase 3]
Phase 3 trial comparing LDK378 (alectinib) to chemotherapy in ALK-rearranged non-small cell lung cancer patients previously treated with pla…